Zobrazeno 1 - 10
of 123
pro vyhledávání: '"Paolo Cossu"'
Autor:
Sandra Orrù, Emanuele Pascariello, Barbara Pes, Vincenzo Rallo, Raffaele Barbara, Marta Muntoni, Francesca Notari, Gianfranco Fancello, Cristina Mocci, Maria Rosaria Muroni, Paolo Cossu-Rocca, Andrea Angius, Maria Rosaria De Miglio
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-14 (2023)
Abstract HER2+ breast cancer (BC) is an aggressive subtype genetically and biologically heterogeneous. We evaluate the predictive and prognostic role of HER2 protein/gene expression levels combined with clinico-pathologic features in 154 HER2+ BCs pa
Externí odkaz:
https://doaj.org/article/36a1b443ba6641c4a88d18e2637049d3
Autor:
Francesca Sanges, Matteo Floris, Paolo Cossu-Rocca, Maria R. Muroni, Giovanna Pira, Silvana Anna Maria Urru, Renata Barrocu, Silvano Gallus, Cristina Bosetti, Maurizio D’Incalci, Alessandra Manca, Maria Gabriela Uras, Ricardo Medda, Elisabetta Sollai, Alma Murgia, Dolores Palmas, Francesco Atzori, Angelo Zinellu, Francesca Cambosu, Tiziana Moi, Massimo Ghiani, Vincenzo Marras, Maria Cristina Santona, Luisa Canu, Enrichetta Valle, Maria Giuseppina Sarobba, Daniela Onnis, Anna Asunis, Sergio Cossu, Sandra Orrù, Maria Rosaria De Miglio
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-14 (2020)
Abstract Background Triple Negative breast cancer (TNBC) includes a heterogeneous group of tumors with different clinico-pathological features, molecular alterations and treatment responsivity. Our aim was to evaluate the clinico-pathological heterog
Externí odkaz:
https://doaj.org/article/ae814c38082d403bbe0df6d096104f57
Autor:
Alessandro Tanca, Marcello Abbondio, Giovanni Fiorito, Giovanna Pira, Rosangela Sau, Alessandra Manca, Maria Rosaria Muroni, Alberto Porcu, Antonio Mario Scanu, Paolo Cossu-Rocca, Maria Rosaria De Miglio, Sergio Uzzau
Publikováno v:
Frontiers in Microbiology, Vol 13 (2022)
Recent studies have provided evidence of interactions among the gut microbiota (GM), local host immune cells, and intestinal tissues in colon carcinogenesis. However, little is known regarding the functions exerted by the GM in colon cancer (CC), par
Externí odkaz:
https://doaj.org/article/0be05936d5504e55a8cade5e48e2231e
Autor:
Sandra Orrù, Emanuele Pascariello, Giovanni Sotgiu, Daniela Piras, Laura Saderi, Maria Rosaria Muroni, Ciriaco Carru, Caterina Arru, Cristina Mocci, Giampietro Pinna, Raffaele Barbara, Paolo Cossu-Rocca, Maria Rosaria De Miglio
Publikováno v:
Biomedicines, Vol 10, Iss 1, p 164 (2022)
HER2+ breast cancer (BC) is an aggressive subtype representing a genetically and biologically heterogeneous group of tumors resulting in variable prognosis and treatment response to HER2-targeted therapies according to estrogen (ER) and progesterone
Externí odkaz:
https://doaj.org/article/bf04c690ceb04924bd09c6ecb2d72a65
Autor:
Andrea Angius, Antonio Mario Scanu, Caterina Arru, Maria Rosaria Muroni, Ciriaco Carru, Alberto Porcu, Paolo Cossu-Rocca, Maria Rosaria De Miglio
Publikováno v:
Medicina, Vol 57, Iss 11, p 1257 (2021)
In the study of cancer, omics technologies are supporting the transition from traditional clinical approaches to precision medicine. Intra-tumoral heterogeneity (ITH) is detectable within a single tumor in which cancer cell subpopulations with differ
Externí odkaz:
https://doaj.org/article/ea6821f704194917a70835626122bcde
Autor:
Silvana Anna Maria Urru, Silvano Gallus, Cristina Bosetti, Tiziana Moi, Ricardo Medda, Elisabetta Sollai, Alma Murgia, Francesca Sanges, Giovanna Pira, Alessandra Manca, Dolores Palmas, Matteo Floris, Anna Maria Asunis, Francesco Atzori, Ciriaco Carru, Maurizio D’Incalci, Massimo Ghiani, Vincenzo Marras, Daniela Onnis, Maria Cristina Santona, Giuseppina Sarobba, Enrichetta Valle, Luisa Canu, Sergio Cossu, Alessandro Bulfone, Paolo Cossu Rocca, Maria Rosaria De Miglio, Sandra Orrù
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-11 (2018)
Abstract Background To provide further information on the clinical and pathological prognostic factors in triple-negative breast cancer (TNBC), for which limited and inconsistent data are available. Methods Pathological characteristics and clinical r
Externí odkaz:
https://doaj.org/article/f09b6cc659d74fc5b059479e4e479c12
Autor:
Alessandro Tanca, Maria Filippa Addis, Salvatore Pisanu, Marcello Abbondio, Daniela Pagnozzi, Albino Eccher, Guido Rindi, Paolo Cossu-Rocca, Sergio Uzzau, Giuseppe Fanciulli
Publikováno v:
Data in Brief, Vol 7, Iss , Pp 529-531 (2016)
Here we present a dataset generated using formalin-fixed paraffin-embedded archival samples from two rare lung neuroendocrine tumor subtypes (namely, two atypical carcinoids, ACs, and two large-cell neuroendocrine carcinomas, LCNECs). Samples were su
Externí odkaz:
https://doaj.org/article/aeac9bb1394942109ac96bc1b3055599
Publikováno v:
Case Reports in Pathology, Vol 2016 (2016)
The Perivascular Epithelioid Cell tumours (PEComas) are rare mesenchymal neoplasms recognized as entity by the World Health Organization. The tumour cells have an uncertain origin and are characterized by distinctive histological and immunohistochemi
Externí odkaz:
https://doaj.org/article/402ec06170c54bcaa8fdffa6928f8a96
Autor:
Paolo Cossu-Rocca, Sandra Orrù, Maria Rosaria Muroni, Francesca Sanges, Giovanni Sotgiu, Sara Ena, Giovanna Pira, Luciano Murgia, Alessandra Manca, Maria Gabriela Uras, Maria Giuseppina Sarobba, Silvana Urru, Maria Rosaria De Miglio
Publikováno v:
PLoS ONE, Vol 10, Iss 11, p e0141763 (2015)
Triple Negative Breast Cancer (TNBC) accounts for 12-24% of all breast carcinomas, and shows worse prognosis compared to other breast cancer subtypes. Molecular studies demonstrated that TNBCs are a heterogeneous group of tumors with different clinic
Externí odkaz:
https://doaj.org/article/3f39da5563554258923b7b556cd528eb
Autor:
Andrea Angius, Giovanna Pira, Paolo Cossu-Rocca, Giovanni Sotgiu, Laura Saderi, Maria Rosaria Muroni, Patrizia Virdis, Daniela Piras, Rallo Vincenzo, Ciriaco Carru, Donatella Coradduzza, Maria Gabriela Uras, Pierina Cottu, Alessandro Fancellu, Sandra Orrù, Paolo Uva, Maria Rosaria De Miglio
Publikováno v:
Journal of cancer research and clinical oncology.
Purpose Triple negative breast cancer (TNBC) is an aggressive clinical tumor, accounting for about 25% of breast cancer (BC) related deaths. Chemotherapy is the only therapeutic option to treat TNBC, hence a detailed understanding of the biology and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::04006339b651ecb356af23fd2ee28578
https://pubmed.ncbi.nlm.nih.gov/36030436
https://pubmed.ncbi.nlm.nih.gov/36030436